lundi 30 mars 2015

Onco-Actu du 30 mars 2015


Les étoiles de couleur jaune signalent des articles dont la lecture est en priorité suggérée (1*) ou recommandée (3*).

2.6 Etiologie - Environnement

Glyphosate and Cancer: What does the data say? [Control Freaks]

He's Not A Monsanto Lobbyist, And Weed Killer Isn't Safe To Drink [Forbes]

3. Prévention

Fit middle-aged men have lower cancer risk [NHS Choices]

Coffee probably prevents liver cancer [Cancer Prevention Blog]

3.1 Tabac

Smoking ban in outdoor areas the 'next logical step', says Melbourne lord mayor [The Guardian]

3.2 Prévention - Obésité

Obesity and cancer – report highlights three things the Government could do [Cancer Research UK]

3.3 Prévention - Vaccins

Gardasil 9 offers wider protection against cancers caused by human papillomavirus (HPV) [EMA]

4. Dépistage, diagnostic et pronostic

Body scans will detect cancer quicker than invasive biopsies [The Telegraph]

5. Traitements

How the Lung-MAP Clinical Trial is Responding to Rapidly Changing Science [The Cancer Letter]

If the drugs don't work on the cancer, transform it [New Scientist]

5.2 Pharma

Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work [Xconomy]

Sanofi chairman says acquisitions not 'indispensable' for future [Reuters]

5.3 Traitements - FDA, EMA,...

Accelerated assessment fast-tracks Lenvima to benefit patients with thyroid cancer [EMA]

Europe postpones decision on Bristol immune system cancer drug [Reuters]

Eisai Receives Approval in Japan for Anticancer Agent Lenvima (Lenvatinib Mesylate) as Treatment for Unresectable Thyroid Cancer [Eisai]

Further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate medicine [EMA]

Eisai gets EMA nod for Lenvima just weeks after FDA approval [FiercePharma]

In swansong, FDA chief defends drug approval process [Reuters]

5.6 ESMO

Clinical Trial Design in the Era of Targeted Therapies [ESMO]

5.8 ASH

Experts Set Strategic Priorities for Lymphoma Research [ASH]

6. Lutte contre les cancers

‘It’s really difficult to be a polymath’ – Sir Paul Nurse on multidisciplinary research [Cancer Research UK ]

6.10 Politiques

More States Pass ‘Right to Try’ Laws, But Will These Make a Difference? [Wall Street Journal]

6.11 Patients

Chatting With Anne Parker: A Patient's View On How Cancer Care Has Changed Since The 1960s [Forbes]

Russian cancer patients are killing themselves because they can’t get pain meds [Quartz]

6.6 Publications

Editor quits journal over pay-for-expedited peer-review offer [Science]

Ask The Chefs: How Can We Improve the Article Review and Submission Process? [The Scholarly Kitchen]

Concern raised over payment for fast-track peer review [Nature News & Comment]

6.8 Communication

The conversation about cancer Angelina Jolie will dread [The Telegraph]

U.K. government scientists hit with media restrictions [Science]

'CANCER: The Emperor of All Maladies' Preview at AACR Annual Meeting 2014 [AACR]

6.9 Controverses

Prostate cancer nurses face extinction at a time when we're most needed [The Guardian]

Opinion: Trying to Fool Cancer